Search filters

List of works by Alfonso Quintas-Cardama

Analysis of outcomes in adolescents and young adults with chronic myelogenous leukemia treated with upfront tyrosine kinase inhibitor therapy

scientific article

Antagonistic activities of the immunomodulator and PP2A-activating drug FTY720 (Fingolimod, Gilenya) in Jak2-driven hematologic malignancies

scientific article published on 07 August 2013

Antileukemia activity of the combination of an anthracycline with a histone deacetylase inhibitor

scientific article published on 4 May 2006

Assessment at 6 months may be warranted for patients with chronic myeloid leukemia with no major cytogenetic response at 3 months

scientific article published on 28 June 2013

Bafetinib, a dual Bcr-Abl/Lyn tyrosine kinase inhibitor for the potential treatment of leukemia

scientific article published on December 2010

Biological and clinical features of trisomy 21 in adult patients with acute myeloid leukemia

scientific article

Dynamics of chronic myeloid leukemia response to long-term targeted therapy reveal treatment effects on leukemic stem cells

scientific article published on 8 June 2011

EUTOS score is not predictive for survival and outcome in patients with early chronic phase chronic myeloid leukemia treated with tyrosine kinase inhibitors: a single institution experience

scientific article

Experimental therapeutics for patients with myeloproliferative neoplasias

scientific article published on 04 October 2010

Granulocyte-colony-stimulating factor (filgrastim) may overcome imatinib-induced neutropenia in patients with chronic-phase chronic myelogenous leukemia

scientific article

HCVAD plus imatinib or dasatinib in lymphoid blastic phase chronic myeloid leukemia

scientific article published on 22 October 2013

Imatinib mesylate therapy may overcome the poor prognostic significance of deletions of derivative chromosome 9 in patients with chronic myelogenous leukemia

scientific article published on 30 November 2004

Improved survival in chronic myeloid leukemia since the introduction of imatinib therapy: a single-institution historical experience

scientific article published on 6 January 2012

Malignancies occurring during therapy with tyrosine kinase inhibitors (TKIs) for chronic myeloid leukemia (CML) and other hematologic malignancies

scientific article published on 16 August 2011

Management of cytopenias in patients with myelofibrosis treated with ruxolitinib and effect of dose modifications on efficacy outcomes

scientific article published on 17 December 2013

Modest activity of pomalidomide in patients with myelofibrosis and significant anemia

scientific article

New agents in the treatment of chronic myelogenous leukemia

scientific article published on October 2009

Nilotinib therapy in chronic myelogenous leukemia

scientific article published on October 2007

Novel approaches in the treatment of systemic mastocytosis

scientific article published on October 2006

Ocular granulocytic sarcoma: a case report and literature review of ocular extramedullary acute myeloid leukemia

scientific article

Outcome after failure of second generation tyrosine kinase inhibitors treatment as first-line therapy for patients with chronic myeloid leukemia

scientific article published on 14 June 2013

Patient-driven discontinuation of tyrosine kinase inhibitors: single institution experience

scientific article

Peripheral blood blast clearance is an independent prognostic factor for survival and response to acute myeloid leukemia induction chemotherapy

scientific article published on 30 July 2016

Ponatinib in Philadelphia chromosome-positive leukemias.

scientific article

Prognostic implications of chromosome 17 abnormalities in the context of monosomal karyotype in patients with acute myeloid leukemia and complex cytogenetics

scientific article

Similar outcome of patients with chronic myeloid leukemia treated with imatinib in or out of clinical trials

scientific article published on 20 September 2013

The achievement of a 3-month complete cytogenetic response to second-generation tyrosine kinase inhibitors predicts survival in patients with chronic phase chronic myeloid leukemia after imatinib failure

scientific article

The achievement of an early complete cytogenetic response is a major determinant for outcome in patients with early chronic phase chronic myeloid leukemia treated with tyrosine kinase inhibitors

scientific article published on 29 July 2011

The clinical significance of achieving different levels of cytogenetic response in patients with chronic phase chronic myeloid leukemia after failure to front-line therapy: is complete cytogenetic response the only desirable endpoint?

scientific article published on 10 August 2011

The economic burden of pleural effusions in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors ⬇️

scientific article published on 06 June 2012

Tyrosine kinase inhibitors as initial therapy for patients with chronic myeloid leukemia in accelerated phase

scientific article published on 09 December 2013

Paulina is supported by:

About Paulina

Help